Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2025-12-24 @ 5:29 PM
NCT ID:
NCT00387868
Eligibility Criteria:
Inclusion Criteria:
* Biopsy-proven thymoma or thymic carcinoma.
* Invasive thymoma determined by specific radiographic criteria determined by CT scan.
* Acceptable kidney, liver, bone marrow, and respiratory functions.
* Karnofsy performance status greater than 80%.
* Patients must have a CT of the chest with IV contrast within 60 days of enrollment.
* Tumors larger than 8cm in greatest diameter on CT scan.
* For tumors 5-8cm in greatest diameter on CT scan, one or more of the following radiographic criteria must also be present on IV contrast CT Scan:
* Multifocal calcification
* Heterogeneous appearance
* Irregular of scalloped borders
* Obvious great vessel invasion or encirclement
Exclusion Criteria:
* Considered unable to medically tolerate surgical resection at the time of initial presentation.
* Radiographic evidence of stage IVA thymoma.
* Pretreatment biopsy showing WHO type A thymoma unless obvious great vessel invasion/encirclement is present on CT scan.
* Previous radiation therapy to the chest which would preclude the administration of radiation.
* Patents receiving other investigational drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00387868
Study Brief:
Protocol Section:
NCT00387868